IL23A and inflammatory bowel disease: Understanding the sources of IL-23 production and its regulatory mechanisms and how IL-23 regulates type 17 immunity in chronic inflammation, particularly in comparison with acute inflammation during gut infections, is crucial for comprehensively delineating IBD pathology and advancing therapeutic interventions.